BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38040059)

  • 1. Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma.
    Sienna J; Kahalley LS; Mabbott D; Grosshans D; Santiago AT; Paulino ADC; Merchant TE; Manzar GS; Dama H; Hodgson DC; Chintagumpala M; Okcu MF; Whitehead WE; Laperriere N; Ramaswamy V; Bartels U; Tabori U; Bennett JM; Das A; Craig T; Tsang DS
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):200-207. PubMed ID: 38040059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma.
    Eaton BR; Fong GW; Ingerski LM; Pulsifer MB; Goyal S; Zhang C; Weyman EA; Esiashvili N; Klosky JL; MacDonald TJ; Ebb DH; MacDonald SM; Tarbell NJ; Yock TI
    Cancer; 2021 Oct; 127(20):3840-3846. PubMed ID: 34255345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
    Acharya S; Guo Y; Patni T; Li Y; Wang C; Gargone M; Ashford JM; Wilson L; Faught A; Reddick WE; Patay Z; Gajjar A; Conklin HM; Merchant TE
    J Clin Oncol; 2022 Jan; 40(1):83-95. PubMed ID: 34714708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
    Kahalley LS; Peterson R; Ris MD; Janzen L; Okcu MF; Grosshans DR; Ramaswamy V; Paulino AC; Hodgson D; Mahajan A; Tsang DS; Laperriere N; Whitehead WE; Dauser RC; Taylor MD; Conklin HM; Chintagumpala M; Bouffet E; Mabbott D
    J Clin Oncol; 2020 Feb; 38(5):454-461. PubMed ID: 31774710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.
    Pulsifer MB; Sethi RV; Kuhlthau KA; MacDonald SM; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):400-7. PubMed ID: 26254679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
    Paulino AC; Mahajan A; Ye R; Grosshans DR; Fatih Okcu M; Su J; McAleer MF; McGovern S; Mangona VA; Chintagumpala M
    Radiother Oncol; 2018 Jul; 128(1):128-132. PubMed ID: 29373195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ; Barrett SA; Mullaney LM
    Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
    Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation.
    Miralbell R; Lomax A; Russo M
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):805-11. PubMed ID: 9240650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
    Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma.
    Toussaint L; Indelicato DJ; Muren LP; Li Z; Lassen-Ramshad Y; Kirby K; Pedro C; Mikkelsen R; Di Pinto M; Høyer M; Stokkevåg CH
    Radiother Oncol; 2020 Jan; 142():140-146. PubMed ID: 31472997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.
    Baliga S; Adams JA; Bajaj BVM; Van Benthuysen L; Daartz J; Gallotto SL; Lewy JR; DeNunzio N; Weyman EA; Lawell MP; Palmer JD; Yeap BY; Ebb DH; Huang MS; Perry AF; MacDonald SM; Jones RM; Tarbell NJ; Yock TI
    Cancer; 2023 Mar; 129(5):764-770. PubMed ID: 36504293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
    Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photon versus proton whole ventricular radiotherapy for non-germinomatous germ cell tumors: A report from the Children's Oncology Group.
    Mak DY; Siddiqui Z; Liu ZA; Dama H; MacDonald SM; Wu S; Murphy ES; Hall MD; Malkov V; Onar-Thomas A; Ahmed S; Dhall G; Tsang DS
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29697. PubMed ID: 35373903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
    Aldrich KD; Horne VE; Bielamowicz K; Sonabend RY; Scheurer ME; Paulino AC; Mahajan A; Chintagumpala M; Okcu MF; Brown AL
    J Neurooncol; 2021 Oct; 155(1):93-100. PubMed ID: 34596831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.